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In situ formation of subepithelial glomerular immune
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In situ formation of subepithelial glomerular immune complexes
in passive serum sickness. Epimembranous glornerular deposition
of circulating immune complexes is considered to be the patho-
genesis of immune complex glomerulonephritis, based on experi-
ments in serum sickness glomerulopathy. A subepithelial local-
ization of immune aggregates, however, was never obtained after
the intravenous injection of preformed immune complexes. Re-
cent studies on heterologous immune complex glomerulo-
nephritis provide evidence of in situ formation of subepithelial
glomerular immune complex aggregates as a second patho-
genetic mechanism. We investigated the existence of a com-
parable mechanism in a serum sickness model of glomerulone-
phritis. A passive immune complex glomerulopathy involving
lysozyme/antilysozyme and bovine serum albumin (BSA)Ianti-
BSA was used to investigate this thesis. Alternating perfusion of
a kidney with antigen and antibody resulted in a granular deposi-
tion of both components along the glomerular basement mem-
brane (GBM). The deposits of immune aggregates were localized
exclusively along the epithelial side of the GBM and were still
present 3 days after the perfusion. Control perfusions with pre-
formed immune complexes or with either BSA or anti-BSA alone
did not result in subepithelial deposition. Conclusion. The alter-
nating excess of antigen and antibody in the circulation might
result in in situ formation of immune complexes localized at the
epithelial side of the GBM.
Formation in situ de complexes inimuns glomérulaires sous épith-
éliaux dans Ia maladie sérique passive. La formation de de-
pots glomerulaires Cpimembraneux de complexes immuns est
considérCe comme un élément pathogénique de Ia glomérulo-
néphrite des complexes immuns a partir d'experiences réalisées
au cours de Ia gomérulonéphrite de la maladie sérique. Cepen-
dant la localisation sous épithéliale des aggrégats immuns n'a
jamais eté obtenue après l'injection intraveineuse de complexes
immuns prC-formés. Des travaux récents sur Ia glomérulonéph-
rite des complexes immuns hétérologues ont fourni des argu-
ments en faveur de Ia formation in situ d'aggregats de complexes
immuns sous épithéliaux comme deuxième mécanisme patho-
génique. Nous avons recherché l'existence d'un mécanisme
comparable dans un modèle de glomCrulonCphrite de Ia maladie
serique. Une glomCrulonCphrite a complexes immuns passils im-
pliquant le lysozyme/anti-lysozyme et Ia serum albumine bovine
(BSA)/anti-BSA a été utilisée pour évaluer cette hypothèse. La
perfusion alternée d'un rein avec l'antigene et l'anticorps a eu
pour consequence un depOt granulaire des deux composants le
long de la membrane basale glomérulaire (GBM). Les depOts
d'aggregats immuns étaient localisés exclusivement le long de Ia
face épithéliale de GBM et existaient encore trois jours après la
perfusion. Les perfusions de contrôle avec des complexes im-
muns preformes ou avec soit BSA, soit anti-BSA seul n'a pas eu
pour consequence Ia formation de depOts sous epithéliaux. Con-
clusion. L'excès successif d'antigène et d'anticorps dans Ia circu-
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lation peut avoir pour consequence Ia formation in situ de com-
plexes immuns localisés a Ia face épitheliale de GBM.
The majority of diseases of the renal glomerulus
in man results from deposition of immune aggre-
gates along the GBM or in the mesangium [1].
These immune aggregates are thought to be derived
from the circulation, and the site of deposition is
determined by the size of circulating immune com-
plexes, as was concluded from experiments with
acute and chronic serum sickness glomerulopathy
[2, 3]. Small soluble immune complexes formed in
antigen-excess were thought to be deposited at the
subepithelial side of the GBM.
Passive administration of preformed immune
complexes of different sizes in experimental ani-
mals, however, only resulted in mesangial local-
ization [4, 5] or did not result in deposition in the
renal glomerulus [6, 7]. Anyway, no subepithelial
localization was observed.
Recently, a different pathogenetic mechanism
was demonstrated for heterologous [8-10] and au-
tologous [11, 12] immune complex glomerulone-
phritis. It was shown that, in these models of gb-
merulonephritis, subepithelial immune aggregates
are formed in situ. In the present study, we investi-
gated whether this pathogenetic mechanism also ap-
plies to other types of immune complex glomerulop-
athy. For this purpose, an unilateral kidney per-
fusion system was used in which the glomeruli were
perfused with antigen and antibody alternately to
induce a separate transit of these constituents
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across the GBM and to create the opportunity for
an in situ formation of immune aggregates.
First, lysozyme was used in these experiments
because it is known that this enzyme has the ability
to bind to anionic sites of the GBM [13]. Sub-
sequent perfusion with antilysozyme antibody
could therefore lead to in situ formation of immune
aggregates in the GBM [9]. Furthermore, perfusion
experiments with BSA and anti-BSA were designed
to establish whether, in this acknowledged system
of studying experimental immune complex glomer-
ulopathy, an in situ formation of subepithelial im-
mune aggregates could also be obtained.
We demonstrate that in both situations unilateral
kidney perfusions resulted in a glomerular immune
complex deposition, exclusively situated sub-
epithelially. Control perfusions with preformed im-
mune complexes or with either bovine serum albu-
min (BSA) or anti-BSA antibody alone did not re-
suit in subepithelial glomerular deposition.
Methods
Experimental animals. All experiments were per-
formed in female Wistar rats 12 to 14 weeks old,
each varying in body weight from 160 to 180 g.
Antigens. Purified BSA (no. A-7638, Sigma
Chemical Co.) and lysozyme (no. L-6876, Sigma
Chemical Co) were obtained commercially.
Antibody. Anti-BSA and antilysozyme antibody
were obtained through immunization of rabbits.
Ten milligrams of the antigen were dissolved in 0.5
ml of sodium chloride (0.9%) and mixed with 0.5 ml
of complete Freund's adjuvant H37Ra (Difco Bacto
no. 3113-60) and administered in 10 s.c. injections
of 0.1 ml each into the back. This procedure was
repeated twice with a 10-day interval. Ten days af-
ter the last injection, the animal was bled, and the
blood was tested for the presence of antibody by
double diffusion in agargel. The IgG fraction was
purified from the serum through precipitation with
ammonium sulphate [14], followed by column chro-
matography on DE 52 (Whatman Ltd., Kent, Eng-
land) with 0.01 M phosphate buffered saline (PBS;
pH, 8.0) as elution buffer. The purified IgG fraction
was dialyzed overnight against PBS and adjusted to
a concentration of 1.5 mg/mi. Just before perfusion
experiments were performed, the purified IgG for
one group of experiments was passed over a Seph-
adex G-200 column to remove aggregates.
Normal rabbit IgG. Normal rabbit IgG was ob-
tained from normal rabbit serum. The procedure of
purification was similar to that described for rabbit
anti-BSA and rabbit antilysozyme antibody.
I,nmune co,nplexes. Immune complexes con-
sisting of BSA and anti-BSA were prepared the day
before use. BSA (200 mg) was dissolved in 10 ml of
PBS (pH, 7.3) to which was added subsequently 15
mg of purified rabbit anti-BSA antibody in 10 ml of
PBS under constant stirring at 37° C. The resulting
solution was centrifuged during 30 mm at x 1900g
and kept overnight at 4° C.
Perfusion methods. Unilateral perfusion of the
left kidney was performed according to a modifica-
tion of the method of Hoyer, Mauer, and Michael
[15], described in detail by Van Damme et al [9].
Rats were anaesthesized with ether. Through a mid-
line incision the aorta and vena cava were exposed
by blunt dissection. After ligation of the tributaries,
tempory clamps were placed on the aorta above the
level of the left renal artery, leaving the circulation
to the right kidney undisturbed. Also clamps were
placed on the aorta 2 cm below the level of the left
renal artery and on the renal vein close to the vena
cava. Through a puncture hole in the aorta, a needle
was inserted and advanced up to the level of the left
renal artery. The renal vein was punctured to let the
blood and perfused fluids escape. PBS (pH, 7.3)
was infused until the kidney became pale and no
visible blood escaped from the punctured renal
vein. Subsequently, the perfusion was continued
with perfusates as listed in Table 1. In case of alter-
nating perfusion with antigen and antibody, the per-
fusion with the antigen was followed by a perfusion
with 2 ml of PBS. Then the antibody was perfused,
followed again by a perfusion with PBS. This proce-
dure was repeated five times. In this way, formation
of immune complexes in the glomerular capillaries
was prevented.
Control perfusions were performed with pre-
formed immune complexes, BSA alone, rabbit anti-
BSA alone, or alternating with BSA and normal
rabbit IgG. The concentration of the perfusates, as
well as the number of experimental animals, is list-
ed in Tables 1 and 2.
The perfusion rate was 5 mI/mm; the pressure,
100 mm Hg; and the total ischaemic period, 20 mm.
After the perfusion procedure, the perfused kidney
was reconnected to the circulation by repairing the
blood vessels with atraumatic sutures (6/0) and re-
moving the clamps. The animals were sacrificed af-
ter intervals varying from 10 mm to 3 days. In one
group of experiments, the perfused left kidney was
not reconnected to the circulation after the per-
fusion. This moment was indicated as t = 0.
Specimens from the perfused left kidney were ob-
tained and prepared for immunofluorescent mi-
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croscopy, light microscopy, and electron micros-
copy. Specimens from the right kidney and the liver
were prepared for immunofluorescent microscopy.
linmunofluorescent microscopy. For this, kidney
specimens were snap-frozen in precooled Freon
(_l000 C) and cut in a cryostate at 4 tsm. After a
washing procedure in PBS (pH, 7.3), the sections
were incubated with antisera for 30 mm at room
temperature, followed by a washing procedure in
PBS. For demonstration of rabbit IgG, fluorescein-
labeled goat antirabbit antibody was used. For dem-
onstration of BSA, fluorescein-labeled goat anti-
BSA antibody was used.
Electron microscopy. Small pieces of tissue (1
mm3) were fixed in 2% glutaraldehyde in 0.1 M
phosphate buffer (pH, 7.38) during 2 hours. The
specimens were subsequently washed three times in
0.1 M phosphate-sucrose buffer (pH, 7.38) during 10
mm each, followed by a fixation in phosphate buf-
fered osmium tetroxide during 1 to 2 hours at 40 C.
The tissues were then dehydrated and embedded in
Epon. Ultrathin sections were cut on an LKB ultro-
tome and stained with 5% uranyl acetate (5 mm at
Table 1. Perfusion schedule and concentrations of perfusates
Experimental groups
Perfusion schedule
2mlPBSa
2 ml Antigen
2 ml PBS
2 ml Antibody
2 ml PBS
repeated 5 times
Antigen: Lysozyme (20 mg/mI)
Antibody: Antilysozyme (1.5 mg/mI)
Antigen: BSA (20 mg/mI)
Antibody: Anti-BSA (1.5 mg/mI)
Antigen: BSA (20 mg/mI)
Antibody: Normal rabbit IgG (1.5 mg/mI)
Antibody: Anti-BSA alone (1.5 mg/mI)
Antigen: BSA alone (20 mg/mI)
Complexb: BSA (20 mg/mI) +
Anti-BSA (1.5 mg/mI)
PBS indicates phosphate buffered saline.
Preformed immune complexes were perfused five times, al-
ternated with PBS.
room temperature) and lead citrate (2 mm at room
temperature). All sections were examined in an
electron microscope (Philips EM-300).
Results
Macroscopic examination showed a slight en-
largement of the perfused left kidney as compared
to the nonperfused right kidney.
Light microscopy of all perfused kidneys showed
widening of the peritubular capillaries and some at-
rophy of the tubules at all moments studied. At t =
3 days, incidentally, perivascular infiltrate was
found. Occasionally, a kidney showed small is-
chemic infarctions.
The results obtained with immunofluorescent mi-
croscopy are listed in Table 2. A granular deposi-
tion of rabbit IgG was observed along the GBM af-
ter alternating perfusion with lysozyme and anti-
lysozyme (Fig. 1). Rabbit IgG was also present
along the peritubular capillaries and in vessel walls.
No rabbit IgG was found in the mesangial area.
Alternating perfusion with BSA and anti-BSA re-
sulted in a granular deposition of both antigen and
antibody along the GBM at all moments studied
(Fig. 2). Rabbit IgG and BSA were also present
along peritubular capillaries, in vessel walls (Fig. 3),
and along the brushborder of proximal tubules in a
more coarse pattern. No mesangial localization was
found. Electron microscopy after alternating per-
fusion with lysozyme and antilysozyme or with
BSA and anti-BSA antibody showed small electron-
dense aggregates, which were localized underneath
epithelial cells or in the filtration slits (Fig. 4). Some
of the epithelial cells showed fusion. No electron-
dense deposits were observed in the GBM or in the
mesangial area. Identical results were obtained af-
ter perfusion with BSA and anti-BSA antibody,
which was chromatographied over Sephadex G-200
prior to the perfusion experiments to remove pos-
sible aggregates.
Controls. In none of the control experiments was
rabbit IgG or BSA found along the GBM with im-
Table 2. Presence of rabbit IgG in the left kidney following perfusion
Perfusate No. of animals
ous localization
Extraglomerular localization at t = 5 hr
Membran
Peritubular
capillaries Vessels Brushbordert = 0 mm t = 5hr t = 3 days
Lysozyme/antilysozymea 9 + + + + + +
BSA/anti-BSA 12 + + + + + +
BSA/normal rabbit IgG 6 — — — — + +
(BSA-anti-BSA) immune complex 8 — — — + —
Rabbit anti-BSA 6 — — — + +
a Alternate perfusion, as listed in Table 1
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Fig. 1. Glomerulus showing fine granular rabbit IgG deposits
along basement metnbranes 5 hours after alternating perfusion
of lvsozwne and antilyso: me (X400).
Fig. 3. Coarse rabbit IgG deposits in a vessel wall 5 hours after
alternating perfusion of BSA and anti-BSA (x400).
glomerular capillaries at t = 0. After 5 hours, the
glomeruli were negative. Some rabbit IgG was also
present in vessel walls and along the brushborder of
proximal tubules. With BSA perfusion, this antigen
was never detected in the kidney. Immunofluores-
cence of the right (nonperfused) kidney and the
liver was always negative. Electron microscopy did
not reveal immune deposits in the glomeruli of con-
trol rats.
Discussion
Fig. 2. Granular staining for rabbit IgG confined exclusively to
the glomerular basement membrane 5 hours after alternating
perfusion of BSA and anti-BSA (x400).
munofluorescence. Perfusion with preformed im-
mune complexes resulted in a coarse deposition of
rabbit lgG and BSA in vessel walls, but no glomeru-
lar staining was observed. In all other control ex-
periments, incidentally, some rabbit IgG was ob-
served in a local and focal irregular pattern in some
Immune complex glomerulopathy in man and in
experimental animals is characterized by the pres-
ence of immune aggregates along the GBM or in the
mesangial area. Apart from heterologous and autol-
ogous immune complex glomerulonephritis [8-10,
12], it is generally accepted that the presence of
these immune aggregates results from deposition of
circulating immune complexes. Studies of chronic
serum sickness glomerulonephritis have shown that
the site of deposition of the circulating immune
complexes in the glomerulus depends on their size
[2, 3, 16]. It was demonstrated that rabbits with
moderate immune response formed medium sized
soluble immune complexes that were deposited in
the glomerular mesangium and in the subendothelial
space. If, however, antigen was injected daily to in-
duce an antigen excess in the circulation, immune
complexes remained small and were deposited
mainly at the subepithelial side of the GBM [16. 17].
-
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Fig. 4. An electron micrograph showing subepithelial electron-dense deposits situated in filtration slits (right arrow) and underneath
fused epithelial cells (left arrow) 5 hours after alternating perfusion of BSA and anti-BSA (X24,500).
This pattern of deposition is identical to that ob-
served in rabbits with serum sickness and with a
low immune response [2, 3, 17] in which immune
complexes are also supposed to be formed in anti-
gen excess. A direct relationship between circulat-
ing immune complexes and the site of their deposi-
tion in glomeruli only can be obtained, however, af-
ter experimental administration of preformed
immune complexes. It appeared that injection of
preformed immune aggregates [18, 19] or in vitro
prepared immune complexes [4, 5] of a different
size [6] never resulted in subepithelial deposition in
glomeruli.
Recently, evidence was provided that in heterolo-
gous {9, 10] and autologous [Il, 12] immune com-
plex glomerulonephritis subepithelially localized
immune aggregates are formed through a local bind-
ing of circulating antibody to antigens present in the
GBM. Besides, it was shown that circulating anti-
body is able to bind to aggregates already present at
the subepithelial side of the GBM in heterologous
immune complex glomerulopathy [20] and serum
sickness glomerulopathy [21].
These considerations prompted us to investigate
whether separate and alternate presentation of anti-
gen and antibody to the glomerulus could result in
the formation of subepithelial aggregates through an
in situ formation of immune complexes. An experi-
mental procedure was used in which perfusion with
antigen and antibody was separated by a perfusion
with buffer to avoid formation of immune com-
plexes in the glomerular capillaries, which could
subsequently be deposited in the GBM. This per-
fusion sequence was repeated five times, to obtain
aggregates large enough to be detected in the elec-
tron microscope.
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First, lysozyme was used for perfusion studies
because this antigen is known to bind to the GBM
[13]. Alternating perfusion with this antigen and its
specific rabbit antibody results in subepithelial im-
mune deposits in the GBM, as observed in immuno-
fluorescence and electron microscopy. Apparently,
the lysozyme in the GBM serves as a nidus to which
the antibody binds, resulting in immune complexes.
Although lysozyme binds to both laminae rarae of
the GBM, the resulting immune complexes are lo-
calized exclusively at the epithelial side of the
GBM. Second, BSA and anti-BSA were perfused
because this antigen and antibody are frequently
used in experimental nephrology in general and in
serum sickness glomerulopathy in particular [2-4,
16, 17]. Although BSA is not known to bind to
structures of the GBM of the rat kidney, an alternat-
ing perfusion with BSA and anti-BSA also resulted
in a subepithelial localization of immune aggregates
as demonstrated with electron microscopy. Appar-
ently, BSA and anti-BSA form immune complex ag-
gregates during their transit across the GBM while
the resulting immune complexes are withheld at the
level of the filtration slit membrane. The sub-
epithelial presence of immune deposits along the
GBM after alternating perfusion with BSA and anti-
BSA does not result from a deposition of circulating
immune complexes following reconnection of the
perfused kidney to the circulation because the non-
perfused right kidney and the liver were always neg-
ative in immunofluorescent microscopy. The possi-
bility exists, however, that during the perfusion
some BSA or anti-BSA remains in the glomerular
capillaries in spite of the PBS perfused between an-
tigen and antibody. Therefore, immune complexes
could be formed in the glomerular capillaries, which
might contribute to the subepithelial localization
observed after alternating perfusion with BSA and
anti-BSA. This, however, is unlikely, because it
was shown that neither immune complexes formed
in antigen-excess (control experiments) nor immune
complexes formed at equivalence or in antibody-ex-
cess [6] were deposited subepithelially in the gb-
meruli.
Data on the exact size of the preformed immune
complexes in our experiments are not available.
The immune complexes used were prepared in anti-
gen-excess because such immune complexes are
thought to be deposited subepithelially in glomeruli
in the chronic serum sickness model [16], although
this localization was never found after passive ad-
ministration of immune complexes formed in anti-
gen-excess [4, 5].
In the experimental animals, the glomerular de-
posits are still present 3 days after perfusion. A fol-
low-up period no longer than this was chosen be-
cause after this period an autologous antibody pro-
duction against the perfused antigens would
probably interfere with the study of the formation of
BSA/anti-BSA immune aggregates.
We were aware that rather unphysiobogic condi-
tions were used to obtain subepithelial localization
of immune aggregates. It is therefore possible that
ischemic conditions during the alternate perfusion
might facilitate penetration of antigen and antibody
in the GBM and their subsequent binding, because
it was shown that under normal conditions endoge-
nous albumine does not penetrate into the GBM
[22]. On the other hand, BSA could not be demon-
strated in the GBM after its perfusion in control ex-
periments. These results differ from those of Mel-
lors and Brzosko [23], who demonstrated fluores-
cein-labeled BSA along the GBM shortly after
injection into mice. The filtration across the GBM
together with the loss of BSA during the prepara-
tion and incubation of the tissue specimens for im-
munofluorescent microscopy might result in the
presence of only minute amounts of BSA in the
GBM, which cannot be detected. This probably is
also the reason for the absence of rabbit anti-BSA
antibody and normal rabbit IgG in the GBM in con-
trol experiments. Although in some control experi-
ments anti-BSA antibody could incidentally be
found in some capillary loops at t = 0, its local and
focal distribution could never account for the dif-
fuse presence of immune aggregates along the GBM
of all gbomeruli. Alternating perfusion with BSA
and anti-BSA antibody, as well as control perfusion
with anti-BSA antibody, resulted in accumulation
of these proteins in vessel walls. A similar local-
ization in vessel walls was obtained after perfusion
of preformed immune complexes, which are prob-
ably too large to be deposited in glomeruli.
The experiments described have shown that sep-
arate and alternating perfusion with antigen and
antibody may result in the formation of sub-
epithelial immune complexes, whereas perfusion
with preformed immune complexes does not result
in glomerular localization at all. Therefore, it is
likely that in chronic serum sickness the alternating
daily excess of antigen and antibody [2, 16, 17]
causes in situ formation of subepithelial glomerular
immune complexes.
The presented results are important for other
glomerulopathies with epimembranous localization
of immune aggregates. Because these and other
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studies [8—12, 21] stress the importance of in situ
formation of immune complexes as pathogenetic
mechanism and because it is unusual to find circu-
lating immune complexes in human membranous
glomerulopathy [24, 25], it might be worthwhile to
search for free circulating antibody and antigen in
this intriguing glomerular disease.
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